New research to detect chemotherapy-related hearing loss early
A new study by researchers at University College London (UCL) has shown that hearing loss caused by the chemotherapy drug cisplatin can be detected outside of an audiology clinic. This paves the way for more accessible monitoring for people undergoing cancer treatment. How cispla
DeafMonitor aggregates Deaf-community news and credits every story to its original publisher. This story was reported by RNID.
Read the full story at RNID
Read the full story at RNID